340B. TURNKEY.

Wilco [wil-co] – verbwill comply.

PATIENT-CARE DRIVEN. FOCUSED. EFFICIENT.

Wilco Data is a patient-care driven advocate focused on aiding your healthcare entity to remain compliant and efficient in this volatile and complex industry to ensure profitability and the long-term viability of your organization for the sake of the patients and communities which you serve.


  1. THE MARKET
    The 340B Drug Pricing Program requires drug manufacturers to provide outpatient drugs to eligible health care organizations/covered entities at significantly reduced prices.

  2. THE PROBLEM
    The 340B landscape is inundated with other companies that do not offer the same type of customized service.

  3. THE PROMISE
    At Wilco Data, we work with covered entities to increase revenue and savings, and minimize risk through the 340B program.

The purpose of the 340B program is to enable covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services. 

  • Only covered entities (CEs) that are actively enrolled in the 340B program are eligible;
  • DSH is largest group: DSH >11.75% AND either state/local government owned or Private, non-profit with state or local govt contract to provide indigent care;
  • For-profit entities are never eligible for participation;
  • For Grantees and Others – typically no additional criteria for eligibility; participation in a specified program is sufficient to allow enrollment for these entities.

See the full list of eligible organizations/covered entities. U.S Department of Health and Human Services. Citing Website. 340B Drug Pricing Program & Pharmacy Affairs. Retrieved 01/ 09/ 2014, from www.hrsa.gov/opa 

INDUSTRY NEWS

    Stay informed on the Coronavirus (COVID-19)

    Be prepared and updated.